AllAnalyst Report
logoMorningstarOctober 27, 2020

ResMed Inc.: ResMed Faces Near-Term Headwinds but Long-Run Strategy and Outlook Sound

Symbols
RMD
Sector(s)
Healthcare
Rating
Premium
Current Price
$209.64
Fair Value
Premium
Economic Moat
Premium
Stewardship
Premium
Summary

ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.

Premium
Subscribe to Yahoo Finance Premium for full access
Read the latest independent research including analyst forecasts, ratings on the US economy, and more. Get individual company and overall sector level recommendations.
Try Premium FREE